Becoña E, López-Durán A, Fernández del Río E, Martínez Ú Changes in the profiles of smokers seeking cessation treatment and in its effectiveness in Galicia (Spain) 2001-10. BMC Public Health. 2014 Jun 17;14:613. doi: 10.1186/1471-2458-14-613.
Charlson ME, Pompei P, Ales KL, MacKenzie CR A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
Finkelstein J, Cha EM Using a Mobile App to Promote Smoking Cessation in Hospitalized Patients. JMIR Mhealth Uhealth. 2016 May 6;4(2):e59. doi: 10.2196/mhealth.5149.
Gram, I T., Larbi, D., & Wangberg, S. C. (n.d.). "Papel original."
Haskins BL, Lesperance D, Gibbons P, Boudreaux ED A systematic review of smartphone applications for smoking cessation. Transl Behav Med. 2017 Jun;7(2):292-299. doi: 10.1007/s13142-017-0492-2. Review.
Keane, L , Anderson, C., Perez, D., & Freeman, B. (2018). The Development and Evaluation of Online Smoking Cessation Services: A Narrative Literature Review. Journal of Smoking Cessation. https://doi.org/10.1017/jsc.2018.8
Lee M, Lee H, Kim Y, Kim J, Cho M, Jang J, Jang H Mobile App-Based Health Promotion Programs: A Systematic Review of the Literature. Int J Environ Res Public Health. 2018 Dec 13;15(12). pii: E2838. doi: 10.3390/ijerph15122838.
Middleton ET, Morice AH Breath carbon monoxide as an indication of smoking habit. Chest. 2000 Mar;117(3):758-63.
Rahmah, S , & Oktamianti, P. (2018). Smoking Cessation Clinic, Hospital's Participation in Supporting a Quit Smoking Program: A Systematic Review. https://doi.org/10.18502/kls.v4i9.3562
Renau, V , Oberst, U., Gosling, S. D., Rusiñol, J., & Chamarro, A. (2013). Translation and validation of the Ten- Item-Personality Inventory into Spanish and Catalan. Aloma, 31(2), 85-97. https://doi.org/10.1027/1015-5759/a000215
Rigotti NA, Clair C, Munafò MR, Stead LF Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2012 May 16;(5):CD001837. doi: 10.1002/14651858.CD001837.pub3. Review.
Sanidad, M De. (2018). Nota Técnica Encuesta Nacional de Salud . España 2017. Sanz, J. (2013). Rendimiento diagnóstico y estructura factorial del Inventario de Depresión de Beck-II ( BDI-II ) Introducción, 29, 66-75.
Tembo AC, Parker V Factors that impact on sleep in intensive care patients. Intensive Crit Care Nurs. 2009 Dec;25(6):314-22. doi: 10.1016/j.iccn.2009.07.002. Epub 2009 Oct 31. Review.
Tobal, J J.M. Casado, M.I. Cano, A, & Spielberger, C. D. (2014). STAXI-2 Inventario de Expresión de Ira Estado-Rasgo. U
Ubhi HK, Kotz D, Michie S, van Schayck OCP, West R A comparison of the characteristics of iOS and Android users of a smoking cessation app. Transl Behav Med. 2017 Jun;7(2):166-171. doi: 10.1007/s13142-016-0455-z.
Ubhi HK, Michie S, Kotz D, Wong WC, West R A mobile app to aid smoking cessation: preliminary evaluation of SmokeFree28. J Med Internet Res. 2015 Jan 16;17(1):e17. doi: 10.2196/jmir.3479.
Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2016 Apr 10;4:CD006611. doi: 10.1002/14651858.CD006611.pub4. Review.
Ylioja T, Cochran G, Chang Y, Tindle HA, Rigotti NA Postdischarge smoking cessation in subgroups of hospitalized smokers: A latent class analysis. Subst Abus. 2017 Oct-Dec;38(4):493-497. doi: 10.1080/08897077.2017.1355870. Epub 2017 Jul 20.
Smoking Cessation in Hospitalized Patients: Efficacy of an Intensive Intervention Program Using an App
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.